<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<title>Monitoring Boundaries for Group Sequential Designs</title>
<meta name="author" content="By Statistical Innovation"/>
<style type="text/css">
.underline { text-decoration: underline; }
</style>
<link rel="stylesheet" href="./reveal.js/dist/reveal.css"/>

<link rel="stylesheet" href="./reveal.js/dist/theme/serif.css" id="theme"/>

<link rel="stylesheet" href="./presentation.css"/>
<link rel="stylesheet" href="./reveal.js/plugin/highlight/zenburn.css"/>
<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
</head>
<body>
<div class="reveal">
<div class="slides">
<section id="sec-title-slide">
<h1 class="title">Monitoring Boundaries for Group Sequential Designs</h1><h2 class="author">By Statistical Innovation</h2><p class="date">Created: 2022-07-06 Wed 09:14</p>
</section>
<section>
<section id="slide-org102f05d">
<h2 id="org102f05d">An example</h2>
<blockquote>
<p>
"This interim analysis will use the <i>O’Brien-Fleming</i> approach with <i>information
fraction</i> 0.77 and <i>overall type-I error</i> controlled at 0.05, with an <i>alpha
spending</i> at the interim analysis of <i>0.021</i>, and an alpha spending at the final
analysis (when all 108 patients complete the study) of <i>0.043</i>"
</p>
</blockquote>
</section>
</section>
<section>
<section id="slide-org4c464bc">
<h2 id="org4c464bc">Today's objectives</h2>
<ul>
<li>Why do we need monitoring boundaries?</li>
<li>How do Pocock and O'Brien-Fleming boundaries work?</li>
<li>How does alpha spending function work?</li>

</ul>
</section>
</section>
<section>
<section id="slide-orge28cc63">
<h2 id="orge28cc63">An Example of RCT</h2>
<ul>
<li>Consider a randomized controlled trial with a continuous endpoint</li>
<li>The <i>goal</i> is to show that the treatment is superior than the control</li>

</ul>
</section>
</section>
<section>
<section id="slide-orgd95425d">
<h2 id="orgd95425d">Group sequential test</h2>
<ul>
<li>A group sequential test monitors a <b>statistic</b> <i>summarizing the difference in
primary responses between the treatment and control groups</i> at <span class="underline">a series of
times</span> during the trial</li>
<li>At interim analyses, if the value of this statistic exceeds some specified
boundary, the trial is stopped and the null hypothesis is rejected</li>
<li>Interim analyses the trial to be stopped early with a <i>valid conclusion</i>
<ul>
<li>Participants are not exposed to ineffective or unsafe treatments (ethical)</li>
<li>Assumptions made at the design stage are checked (administrative)</li>
<li>Sample size, time and cost are not wasted (economic)</li>

</ul></li>

</ul>
</section>
</section>
<section>
<section id="slide-org02f0feb">
<h2 id="org02f0feb">Information fraction</h2>
<ul>
<li>Defined as the fraction of <i>total information</i> expected at the scheduled end of
the trial</li>
<li>Roughly, \(\mbox{IF} = {n_k \over N}\)</li>

</ul>
</section>
</section>
<section>
<section id="slide-org772be0c">
<h2 id="org772be0c">Type I error inflation</h2>
<table border="2" cellspacing="0" cellpadding="6" rules="groups" frame="hsides">


<colgroup>
<col  class="org-right" />

<col  class="org-right" />
</colgroup>
<thead>
<tr>
<th scope="col" class="org-right">Number of Interim Analysis</th>
<th scope="col" class="org-right">Type I error (for \(\alpha = 0.05\))</th>
</tr>
</thead>
<tbody>
<tr>
<td class="org-right">1</td>
<td class="org-right">0.083</td>
</tr>

<tr>
<td class="org-right">2</td>
<td class="org-right">0.107</td>
</tr>

<tr>
<td class="org-right">3</td>
<td class="org-right">0.126</td>
</tr>

<tr>
<td class="org-right">10</td>
<td class="org-right">0.193</td>
</tr>
</tbody>
</table>
</section>
</section>
<section>
<section id="slide-orgc7fadd7">
<h2 id="orgc7fadd7">Boundaries</h2>
<ul>
<li>Pocock
<ul>
<li>Constant for all analyses: \(c(K)\)</li>
<li>Narrower initially, easier to stop early</li>

</ul></li>
<li>O'Brien-Fleming
<ul>
<li>Narrower boundaries at later analysis (i.e., conservative initially): \(c(K) / \sqrt{k}\)</li>
<li>Similar boundary at the final analysis to the fixed sample test</li>

</ul></li>

</ul>
</section>
</section>
<section>
<section id="slide-orgcbbc2e6">
<h2 id="orgcbbc2e6">Alpha?</h2>
<ul>
<li>Nominal significance level at the \(k\)th interim analysis
<ul>
<li>\(\alpha_k = \Pr(|Z_k| \geq c_k)\)</li>
<li>Probability of rejecting the null hypothesis at the \(k\)th interim analysis</li>

</ul></li>
<li>The error spent at stage \(k\)
<ul>
<li>\(\pi_k = \Pr(|Z_1| < c_1, \ldots, |Z_k| \geq c_k)\)</li>
<li>Probability of <i>not</i> rejecting \(H_0\) before the \(k\)th interim analysis
<i>and</i> rejecting the null hypothesis at the \(k\)th interim analysis</li>

</ul></li>
<li>Cumulative alpha
<ul>
<li>\(\alpha = \pi_1 + \ldots + \pi_K\)</li>
<li>\(\alpha \neq \pi_1 + \ldots + \pi_K\)</li>

</ul></li>

</ul>
</section>
</section>
<section>
<section id="slide-org6a6d84f">
<h2 id="org6a6d84f">Alpha spending function</h2>
<ul>
<li>Any function can be an alpha spending function if the function satisfies
<ul>
<li>\(\alpha(0)=0\) (value equals \(0\) at the beginning of the study)</li>
<li>\(\alpha(1)=\alpha\) (value equals \(alpha\) at the final analysis)</li>
<li>Non-decreasing</li>

</ul></li>
<li>A more flexible group sequential procedure that <i>does not require the total
number nor the exact time of the interim analyses to be specified in advance</i></li>

</ul>
</section>
</section>
<section>
<section id="slide-org299e81b">
<h2 id="org299e81b">Reference</h2>
<ul>
<li>Pocock, Stuart J. "Group sequential methods in the design and analysis of
clinical trials." Biometrika 64.2 (1977): 191-199.</li>
<li>O'Brien, Peter C., and Thomas R. Fleming. "A multiple testing procedure for
clinical trials." Biometrics (1979): 549-556.</li>
<li>Jennison, Christopher, and Bruce W. Turnbull. Group sequential methods with
applications to clinical trials. CRC Press, 1999.</li>
<li>Meurer, William J., and Juliana Tolles. "Interim Analyses During Group
Sequential Clinical Trials." JAMA 326.15 (2021): 1524-1525.</li>
<li>Demets, David L., and KK Gordon Lan. "Interim analysis: the alpha spending
function approach." Statistics in medicine 13.13‐14 (1994): 1341-1352.</li>

</ul>
</section>
</section>
</div>
</div>
<script src="./reveal.js/dist/reveal.js"></script>
<script src="./reveal.js/plugin/markdown/markdown.js"></script>
<script src="./reveal.js/plugin/highlight/highlight.js"></script>
<script>
// Full list of configuration options available here:
// https://github.com/hakimel/reveal.js#configuration
Reveal.initialize({

controls: true,
progress: true,
history: false,
center: true,
slideNumber: false,
rollingLinks: false,
keyboard: true,
mouseWheel: false,
fragmentInURL: false,
hashOneBasedIndex: false,
pdfSeparateFragments: true,
overview: true,
margin: 0.10,

transition: 'convex',
transitionSpeed: 'default',

// Plugins with reveal.js 4.x
plugins: [ RevealMarkdown, RevealHighlight ],

// Optional libraries used to extend reveal.js
dependencies: [
]

});
</script>
</body>
</html>
